Insider · CIK 0001624621
Eric Norris
officer
Files at ALB (ALBEMARLE CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | ALB ALBEMARLE CORP | AGrant or award Common Stock | +10,867 | $0.00 | $0 | 64,310 | 26 d ago |
| Feb 27, 2025 | ALB ALBEMARLE CORP | AGrant or award Common Stock | +7,915 | $0.00 | $0 | 54,511 | Mar 3, 2025 |
| Feb 27, 2025 | ALB ALBEMARLE CORP | AGrant or award Stock Optionsderivative | +18,492 | $0.00 | $0 | 18,492 | Mar 3, 2025 |
| Feb 26, 2025 | ALB ALBEMARLE CORP | FTax withholding Common Stock | -254 | $77.53 | $20k | 44,097 | Feb 28, 2025 |
| Feb 27, 2025 | ALB ALBEMARLE CORP | MOption exercise Common Stock | +3,518 | $0.00 | $0 | 47,615 | Feb 28, 2025 |
| Feb 27, 2025 | ALB ALBEMARLE CORP | FTax withholding Common Stock | -1,019 | $78.97 | $80k | 46,596 | Feb 28, 2025 |
| Feb 27, 2025 | ALB ALBEMARLE CORP | MOption exercise Performance Stock Unitsderivative | -3,518 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 25, 2025 | ALB ALBEMARLE CORP | FTax withholding Common Stock | -510 | $78.42 | $40k | 43,476 | Feb 27, 2025 |
| Jan 1, 2025 | ALB ALBEMARLE CORP | MOption exercise Common Stock | +1,750 | $0.00 | $0 | 44,586 | Jan 3, 2025 |
| Jan 1, 2025 | ALB ALBEMARLE CORP | FTax withholding Common Stock | -600 | $86.08 | $52k | 43,986 | Jan 3, 2025 |
| Jan 1, 2025 | ALB ALBEMARLE CORP | MOption exercise Performance Stock Unitsderivative | -1,750 | $0.00 | $0 | 0 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.